Wellgistics Health has officially completed its name change to DataMEDS AI, Inc. The company will begin trading under the new stock symbol MEDS on the NASDAQ Capital Market on Wednesday, July 22, 2026. The rebranding reflects a vertically aligned healthcare ecosystem that expands the EinsteinRx AI platform into medical, laboratory, and wearables fields through a proprietary blockchain. DataMEDS AI aims to consolidate electronic health data into its health-centered blockchain infrastructure, enabling patients to participate in data transaction revenue and receive tailored clinical trial offerings. The company's Health Lives Here app will initially target GLP-1-associated muscle loss and Long COVID patient bases.
Wellgistics Health, Inc. Common StockCompany rebrands to DataMEDS AI, expanding its AI platform into new fields and launching a blockchain-based health data ecosystem.